A haematopoietic SCT (HSCT) can cause severe side effects, which may have a profound impact on a patient's life both physically and psychologically. Some studies have shown that physical activity has positive effects for inpatients after an HSCT. Therefore, the question arises whether a controlled exercise programme right from the beginning of the conditioning phase could help contribute to a patient's physical and psychological recovery. To evaluate the different effects of specific, moderate physical activities on the physical and psychological condition of HSCT patients we performed a controlled randomized study with 64 inpatients undergoing an allogeneic or autologous HSCT. The patients were randomly assigned to two groups. Although the training group took part in a specific programme of exercise therapy twice a day throughout the entire hospitalization phase, patients in the control group were offered the hospital's standard mobilization programme. The results of this study showed significant differences in favour of the training group regarding strength, endurance, lung function and quality of life. However, further studies are needed to confirm these results.
Introduction
Considerable side effects and a high mortality rate are associated with a haematopoietic SCT (HSCT), especially in allogeneic transplants. [1] [2] [3] [4] [5] [6] During aplasia or severe neutropenia patients are isolated and are not allowed to leave their rooms for several weeks. This usually leads to immobility, which may result in muscle atrophy or pneumonia, which can then become life threatening. 7 In addition, the psychological burden is enormous and more than 50% of all patients still suffer from fatigue half a year after the transplantation. All of these factors have a detrimental effect on their quality of life, as several studies have shown. [8] [9] [10] [11] Physical exercise programmes still play only a minor role in the treatment of cancer inpatients. However, the situation during the rehabilitation phase is slightly different, as more interventions focusing on exercise can be identified, especially after breast cancer, although no studies support this trend towards an increased offer of exercise therapy. 12 Different therapeutic exercise interventions for the individual cancer entities are necessary due to varying medical treatments and side effects.
The first usage of therapeutic exercise interventions in oncological follow-up treatment and rehabilitation of breast cancer patients were made in Germany about 25 years ago. It became apparent that exercise had a positive physical and psychological effect. 13 Due to this experience, and further studies, [14] [15] [16] exercise therapy gained importance as a part of oncological treatment. Existing views that early exercise parallel to and immediately after medical therapy would pose a health risk to the patient and should only be introduced after a CR and in conjunction with rehabilitating measures, are now proven to be incorrect. 14, 17 However, only few studies have examined the impact of exercise therapy on HSCT patients as part of the transplant programme.
The first publication which showed positive effects of rehabilitating measures after an HSCT appears to be that of Cunningham et al. in 1986 . 18 Later studies and case reports also demonstrated significant positive influences on the patients' physical and mental condition. However, these were almost exclusively the patients who had undergone an autologous transplantation and were already in the rehabilitation phase. [19] [20] [21] [22] [23] More recently, studies by Mello et al. and Kim provide the first information on physical activities after patients received an allogeneic transplantation, 24, 25 but no studies have emerged so far concerning the effects of exercise therapy on HSCT patients during the phase of conditioning and the immediate post-transplant period. However, regular physical activity may be very important during these phases to counteract the consequences of immobility. HSCT patients are often treated under isolated conditions for 3 weeks on average and many have to stay in the hospital for several months. Complications such as muscle atrophy, loss of physical performance, cachexia, pneumonia, GVHD and deterioration of the psychological condition are clearly more common in allogeneic than in autologous transplants. [26] [27] [28] [29] The aims of a physical activity plan could include a narrowing down of these complications and their consequences.
The purpose of this study was to evaluate the effects of supervised exercise therapy for the patient group in question. Primary concerns of the study were patient endurance, strength and quality of life. Secondary concerns were haematopoietic parameters and lung function. Due to existing research, we assumed that physical exercise therapy would improve endurance, 12 strength 24 and some areas of the quality of life. 30 Regarding the secondary concerns, we assumed that a physical exercise intervention would have a positive effect on haematopoietic parameters 12, 25 and lung function.
Patients and methods
A controlled, randomized pilot study was performed at the centre for transplantation in Idar-Oberstein, Germany. On the day of their admission (between 6 and 9 days before transplantation), 64 inpatients were randomly assigned to either a training group (TG) or a control group (CG). As this was a mono-centre pilot study, sample size calculation was not based on a statistical but on a pragmatic approach. For the scope of this thesis the aim was to recruit at least 60 patients within a period of approximately 2 1 2 years. All patients were thoroughly examined before the hospitalization period and were checked again just before admission for transplantation. The accrual of patients took place between March 2002 and July 2004. Randomization was achieved by using a computer-generated sequence of random numbers (PopTools as add-in in Microsoft Excel). This study was approved by the local ethics committee.
Inclusion and exclusion criteria
The criteria for participating in this study were as follows: malignant disease with the indication of an HSCT, patients aged 18 years or more, good German language skills and the written consent of the patient. The treating physicians of the transplant department collectively approved the enrolment of patients onto the study.
Exclusion from this study occurred in the cases of severe orthopaedic illnesses of the legs, severe heart failure (NYHA III-IV), metastatic bone disease, thrombopenia (thrombocytes p30/nl) and/or acute somatic complaint (infection, fever, acute bleeding). In this study, 3 of initially 67 patients were excluded because their thrombocytes were under 30/nl on hospital admission.
Sport score
All patients were asked to describe their previous exercise or sport activities. Patients were able to indicate their own activities somewhere between 1 (never performed sport activities) and 10 (regular high-performance sport) by means of subjective rating on a visual analogue scale.
Exercise programmes
Usually starting 6 days before transplant the TG received exercise therapy twice a day. It included a combination of aerobic endurance training on a bicycle ergometer and an 'ADL-training' (ADL: activities of daily living). The training as well as the CG were attended by a professional therapist at all times. The duration of the aerobic endurance training ranged from a minimum of 10 min to a maximum of 20 min without interruption. If this was not possible, the patients tried to achieve the set times by means of an interval training. The intensities of the training were defined as follows: first of all, the WHO-endurance test on the bicycle ergometer was carried out by increasing the load by 25 W every 2 min. The test was aborted as soon as the patient reached a heart rate of 180 minus the patient's age. Of the achieved watt load, 20% was subtracted and the resulting value was used as the patient's training load. However, due to occurring changes in a patient's medical condition and state of health, the training had to be reviewed every day. The ADL-training included elements of everyday life to maintain the patient's mobility in their daily routine after hospital discharge. During chemotherapy and after engraftment the patients took part in a daily 20 min exercise programme of walking, stepping and stretching. However, these key aspects of training were altered from day to day. Walking was done on the hospital's corridor. If the patients were not able to leave their room, a 30-cm high step was used for stepping. Stretching was performed while standing in front of the bed or while lying down in bed. The intensity of the ADLtraining was meant to match the patient's subjective feeling of 'slightly strenuous' to 'strenuous' (Borg scale). 12 For safety reasons the pulse frequency and blood pressure was not to exceed 150/min and 150/90 mm HG, respectively. In case of paleness, nausea, vomiting, headache, dizziness, hyperventilation and others the exercises were stopped immediately.
Patients in the CG received a so-called passive and active mobilization with a low intensity. This was conducted on 5 days a week, on working days, throughout the entire hospitalization period. It consisted of gymnastics, massages, extensions and coordination training. The mobilization therapy started 1 day after the transplantation and lasted until 1 day before hospital discharge. The training programmes of both study groups are summarized in Table 1 .
Contraindications
The exercise therapy was interrupted, or not performed at all, in cases where patients experienced any of the following complications: acute bleeding, thrombocytes below 10/nl or 10-20/nl (depending on individual inclination to bleeding), strong pain, restricted consciousness, somnolence, confusion, poor blood circulation, dizziness, Hb count below 8 g/100 ml, fever (temperature above 38.0 1C), severe infection, nausea and vomiting, and on the days of receiving cardiac or nephrotoxic medication during chemotherapy (Table 1) .
Physical tests
The patients' endurance, strength, lung function and blood count were tested on admission (before conditioning, all 64 patients) and on the day of hospital discharge (surviving patients). To measure the endurance performance a slightly modified endurance test according to the WHO scheme [31] [32] [33] was used. The pulse limit under stress was set to 180 minus the patient's age. The starting load of 25 W was increased by 25 W every 2 min, until the previously defined upper pulse limit was reached. The test was aborted as soon as the pulse limit was exceeded. On completion of this submaximal perseverance test, 80% of the achieved watt load was set as an upper limit for subsequent exercises. The strength performance was tested with a specific box ('Digimax' by Mecha Tronic GmbH, Hamm, Germany), which examines the extensor muscles of the thighs. This isometric strength test was conducted while the patients were sitting down. 34 Testing the lung function was done with a Flowscreen Version 6.00d, Erich Jaeger (Wu¨rzburg, Germany). The two parameters, inspiratory vital capacity (IVC) and forced vital capacity (FVC), were used to demonstrate a potential improvement of lung function, which might also contribute to a better prophylaxis of pneumonias. 35, 36 Daily blood counts were conducted to demonstrate a possible influence of therapeutic exercise and activities on haematology Neutrophil engraftment was definded as the first of 3 consecutive days with neutrophils X0.5/nl. The application of RBC and plts packs was also recorded.
Quality of life
The quality of life of each patient was assessed during hospitalization by using the EORTC QLQ-C30 questionnaire on days -6, þ 1, þ 8, þ 14 and further every fortnight until discharge. The questionnaire analyses the cancer patient's psychological and psychosocial condition by means of 30 questions. The instrument tests the healthrelated quality of life and includes 15 areas and items (see Table 1 ). 37 So far, the EORTC QLQ-C30 questionnaire has only been used in a few studies with HSCT patients, and in almost all of these cases the subjects were not inpatients. [38] [39] [40] As this questionnaire is internationally standardized and has shown a high reliability and validity in many studies with cancer patients it was also used for this study. 40 
Statistics
All 64 randomized patients represented the 'intent-to-treat' population. At the time of discharge, data for analysing the physical parameters endurance, strength and lung fuction were available for 24 surviving patients of the TG, and 25 surviving patients of the CG.
All statistical analyses were performed using SPSS German version 8.0 for Windows (SPSS Software GmbH, 
Results
The patients' characteristics together with their disease-and transplant-specific data are summarized in Table 2 . Neither study group showed any statistically significant differences concerning the various parameters. The CG had a higher percentage of female patients (56%) than the TG (34%), which, however, had no statistical relevance.
Of the 64 patients initially randomized, 15 (8 of the TG and 7 of the CG) deceased during hospitalization for HSCT. With only one exception (progression of underlying disease: 1 in TG), the cause of death in all patients was a transplant-related mortality (GVHD: 2 in TG, 4 in CG; infection: 2 in TG; toxicity: 2 in TG, 2 in CG; bleeding: 1 in TG, 1 in CG).
Within the TG, all patients had to interrupt some exercises during their training period as outlined under contraindications (Table 1) . None, however, had to drop out of the study prematurely except for those suffering transplant-associated deaths or progression of disease. Overall, the patients of the TG exercised 26.6 days on average, whereas the CG demonstrated 22.4 days of exercise (P ¼ 0.180, t-test). On average, in the CG 10.6 and in the TG 11.5 days of training could not take place due to a contraindication. Yet, no significant difference could be observed. Table 3 summarizes the development of the submaximal endurance capacity of the TG in comparison to the CG.
Endurance

A part of
Although the endurance performance of the TG remains nearly unchanged during the training period during hospitalization (88.3 vs 86.5 W, difference 2%), it decreases quite substantially in the CG (82.0 vs 60.0 W, difference 27%). When comparing the endurance values between both groups for the entire course of hospitalization, highly significant differences (P ¼ 0.004, group by time interaction) appear. Within the TG the endurance time remains nearly constant. In contrast, the patients of the CG had to finish the endurance test almost 2 min earlier at discharge than they did at admission. The parameter 'endurance time' differed significantly between the two study groups (P ¼ 0.004, group by time interaction). Further, the results demonstrate that the relative endurance increases in the TG, whereas it decreases in the CG (P ¼ 0.031, group by time interaction).
Strength
The development of the strength curves is presented in Figure 1 . The CG has a slightly higher initial strength value than the TG. Both curves decline during hospitalization. However, the decline is much greater in the CG (24%) than it is in the TG (10%). At the time of discharge from the hospital, the patients of the TG show 13% higher strength values on average compared to the CG. These developments are highly significant when compared to each other (P ¼ 0.002, group by time interaction). 
Quality of life
Results of the EORTC QLQ-C30 are described in Table 4 . The data reflects the 15 items of quality of life raised at admission and discharge (with regard to the non-surviving patients: at the last available test day before death). In general, at the time of discharge the patients of the TG rated their quality of life higher in 12 of 15 items compared to the patients of the CG. Two of these items showed significant differences (global quality of life: P ¼ 0.037; physical functioning: P ¼ 0.039). However, these differences were not evident with regard to the development during hospitalization, as shown by analysis of variance for repeated measurements (global quality of life: P ¼ 0.160; physical functioning: 0.157).
Haematology
As expected, the main haematological parameters (leucocytes, plts, Hb) decline in both groups due to the pretransplant conditioning. Statistically significant intragroup differences are noted for all parameters, except for the leucocytes in the TG (Table 3 ). The study period was rather short (average approximately 6 weeks post transplant) to observe a full recovery of the mentioned parameters. Nevertheless, most evaluated patients showed a stable neutrophil engraftment during the exercise period, which did not differ between the study groups.
Lung function
The results of the lung function tests for the TG, as well as for the CG, are also presented in Table 3 . Although the lung function values for the TG remain mostly unchanged, and even improve slightly (IVC þ 1%, FVC þ 4%), the values for the CG show a reverse trend (IVC À5%, FVC À2%). However, the respective intragroup changes during hospitalization are not significant. It is remarkable that the intergroup comparisons are already significantly different at the point of hospital admission. This cannot be explained and therefore no further conclusion can be drawn. Nevertheless, one should consider the trends mentioned above, because there were less patients in the CG receiving TBIbased conditioning (that is, less lung toxicity) and more patients with reduced intensity conditioning (see Table 2 ). During the transplantation period, five cases of pneumonia were diagnosed in the CG and only three cases in the TG.
Discussion
The medical progress of recent years in the field of HSCT also demands new ways in rehabilitation. Currently, rehabilitation is, to a major extent, focused on the post-transplant phase after hospital discharge. Exercise therapy as part of the rehabilitation program during the acute treatment phase is still in its infancy. Only very few controlled randomized studies exist that demonstrate the effects of physical activities during an HSCT. A study by Dimeo et al. observed positive effects of endurance training on haematopoiesis and physical power of patients after an autologous transplantation and highdose chemotherapy. 12 This study tested the potential influence of therapeutic exercise interventions during the complete transplant phase, from the conditioning phase until discharge.
With regard to the primary endpoints, this study showed that a specifically devised training for the entire clinical phase of transplantation has positive effects on several physical and psychological parameters of HSCT patients. The described results of the endurance tests might confirm an influence of exercise therapy on the submaximum endurance ability in favour of the patients in the TG. Dimeo et al. have described endurance training for autologous transplants during hospitalization, directly following high-dose chemotherapy by using a bed ergometer. 12 The authors of that particular study, were finally able to determine a significant difference of 27% in the endurance abilities between the control and TG at the time of their hospital discharge. In this study similar results were achieved regarding endurance. However, this study includes an examination of patients receiving an autologous as well as patients receiving an allogeneic transplantation. Differences were also noticed in the strength development between the two study groups comparable with the results of the endurance ability. Although the patients of the TG were nearly able to maintain their strength, with a loss of only 10%, the loss of strength in the CG was more than twice as high (24%). Mello et al. reported comparable results for muscle performance in a similar study, in which 18 transplant patients were randomized to a training or CG after engraftment. 24 Generally, we noticed less patients with physical deterioration in our study (that is, with regard to strength and endurance; see Table 3 and Figure 1 ) compared to some previous publications in which 31% of the patients displayed a clear loss of strength. 2, 41 Regarding the CG, however, observations matched the ones made by Baker et al.
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When comparing the development of the quality of life between the two study groups, only a few significant differences, that is, global quality of life and physical functioning, became apparent in favour of the patients in the TG. One can hypothesize that exercise therapy probably helped maintain or even improve some qualityof-life items of these patients. This outcome is supported by results observed by Courneya et al. 30 These authors found that the duration of daily bike riding directly correlated with the quality of life of HSCT inpatients. Similar results indicated a positive influence of physical exercise on the level of fatigue in HSCT patients. 12 No patient in that study complained about fatigue after receiving exercise therapy. In 1999, Dimeo et al. also examined the influence of exercise therapy on inpatients who had received an autologous HSCT. 42 The CG showed significant deterioration regarding fatigue, whereas the TG did not suffer any changes.
Regarding the secondary endpoints, our study results do not provide a definite result. A clear influence of exercise on patients' haematology, as shown by Dimeo et al., 12, 43 could not be confirmed in our study. This might be due to the high proportion of allogeneic transplants in our study. Leucocytes, plts and Hb significantly declined in both study groups. With regard to lung function, patients of the TG could slightly improve their FVC and maintain their IVC, whereas patients of the CG experienced a minor deterioration in both parameters. One can speculate that the observed differences in lung function may indicate a prophylactic effect regarding pneumonia, but this has to be verified in future studies. It cannot definitely be confirmed where adaptations occurred. Yet, a training-related adaptation of the lung can almost certainly be ruled out, as only conditional adaptations took place in this case. 44 The results of our pilot study do have some limitations. There is a major methodological flaw in our study because the TG was given more time to exercise (4.1 days, 18% more; see Table 1 ; though statistically not significant, P ¼ 0.180). Although the CG only received their intervention once a day, the TG had an extra unit of physical exercise every day during aplasia (see Table 1 ). The question arises whether the CG might work equally well if patients of this group received as much a dose of the control intervention as did those in the TG. In addition, this was not a blind study, and this is an important factor in interpreting the results of quality-of-life assessments.
To summarize, our pilot study suggests that therapeutic exercise interventions may have some positive effects on the patient's physiological, psychological and psychosocial level during the entire phase of an HSCT. The training program did not pose additional risks to HSCT patients; on the contrary, it seemed to contribute to the recovery process of the patient. We assume that it was possible to reduce the consequences of immobility and thus improve some parts of quality of life. At the same time it demonstrates that exercise therapy is not only suited for specially selected patients. In fact, all patients can be involved by employing individually devised programs that are based on practical and everyday considerations. To avoid the consequences of immobility and complications resulting from cancer therapy, exercise therapy should probably be offered to a patient right from the beginning of the acute phase of therapy on. This way cancer patients can possibly contribute to their own recovery, maintain mobility, reduce the incidence of pneumonias and improve the quality of their lives. Finally, the effects of exercise therapy as part of the acute phase and rehabilitation should also be examined in other cancer patients outside the transplant setting to derive a benefit from exercise therapy. Larger studies are necessary to find exact answers to the assumptions and suggestions of our pilot study.
